Navigation Links
PDL BioPharma to Announce Third Quarter 2010 Financial Results on November 10, 2010
Date:11/2/2010

INCLINE VILLAGE, Nev., Nov. 2, 2010 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the Company will release its third quarter financial results on Wednesday, November 10, 2010 after the markets close. PDL's management will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the financial results.  

Conference Call Details

To access the live conference call via phone, please dial (866) 271-5140 from the United States and Canada or (617) 213-8893 internationally. The conference ID is 98631412. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through November 17, 2010, and may be accessed by dialing (888) 286-8010 from the United States and Canada or (617) 801-6888 internationally. The replay passcode is 74992654.

To access the live and subsequently archived webcast of the conference call, go to the Company's website at http://www.pdl.com and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed by leading pharmaceutical and biotechnology companies today based on patents which expire in late 2014. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.


'/>"/>
SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Researchers prolong the half-life of biopharmaceutical proteins
2. Science survey ranks top biopharma employers
3. GREENBioPharma -- Dec. 2-3, 2009
4. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
5. 2008 SNM Wagner-Torizuka Fellowships announced
6. NIAID announces 25 new awards to develop radiation countermeasures
7. Aware Announces Q3 2008 Earnings Conference Call
8. Governor Doyle announces historic genomic research collaboration
9. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
10. San Diego Supercomputer Center and UCSD announce Triton Resource
11. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- The report "Gesture Recognition and Touchless Sensing Market by Technology ... Forecast to 2022", published by MarketsandMarkets, the market is expected to be worth ... and 2022. Continue Reading ... ... ...
(Date:3/22/2017)... , March 21, 2017 Optimove ... used by retailers such as 1-800-Flowers and AdoreMe, ... — Product Recommendations and Replenishment. Using Optimove,s machine learning ... personalized product and replenishment recommendations to their customers ... on predictions of customer intent drawn from a ...
(Date:3/20/2017)... PMD Healthcare announces the release of its ... System (WMS), a remote, real-time lung health monitoring and ... is a Medical Device, Digital Health, and Chronic Care ... innovative solutions that empower people to improve their healthcare ... developed the first ever personal spirometer, Spiro PD, which ...
Breaking Biology News(10 mins):
(Date:6/28/2017)... , June 28, 2017  Scientific Analytics, Inc.,s DARI ... showcased in front of thousands of healthcare providers at Premier ... 27.   Scientific Analytics, DARI Motion Health was debuted ... recognizes advances in healthcare while highlighting industry suppliers committed to ... ...
(Date:6/28/2017)... 28, 2017 Michael Zasloff , MD, ... School of Medicine, and Founder, Chairman and CEO of ... that has helped clarify the function of alpha-Synuclein (aS), ... neurodegenerative diseases. Denise Barbut , MD, FRCP, Co-Founder, ... senior co-author of the study. Published in ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... with three research projects accepted for presentation at the 33rd Annual Meeting of ... participants – including some of the world’s top thought leaders in reproductive medicine ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... for multiphysics computational fluid dynamics (CFD) simulation and analysis includes two new ... version 12.04 introduces Design Manager, allowing users to easily explore multiple design ...
Breaking Biology Technology: